AVAlberto Viñals

Alberto Viñals

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alberto Viñals has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Salvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site

    by Enrique Amaya, Jacobo Palma, Roser Fayós-Solà, Rosa Meiriño, Mauricio Cambeiro, Ana Navarrete, Pablo Cabello-García, Alberto Viñals, Diego Pedrero, Felipe A. Calvo, et al.

    Background/Objectives: Photon re-irradiation in previously treated head and neck cancer (HNC) is constrained by cumulative normal-tissue toxicity. Pencil-beam scanning intensity-modulated proton therapy (PBS-IMPT) allows for a sharper dose conformation than conventional photon techniques, which may widen the therapeutic window in previously irradiated tissue. Methods: Sixty-five patients with recurrent or second primary HNC were enrolled in a prospective single-institution registry and re-irradiated with PBS-IMPT between January 2020 and December 2025. Forty-five were treated with radical intent (69.2%), and 20 were treated postoperatively (30.8%), with a median prescribed dose of 66 Gy (RBE) in 30 fractions. Primary endpoints were overall survival (OS) and progression-free survival (PFS). Locoregional control (LRC), adverse events and the prognostic impact of anatomical extent were secondary endpoints. Results: The median follow-up was 9.3 months. The median OS was 17.2 months (95% CI 13.9–NR), with a 12-month rate of 67.1%. The median PFS was 10.1 months and the median LRC was 28.1 months. Central/skull-base involvement was associated with a non-significant trend toward worse OS (14.3 vs. 35.2 months; p = 0.062) and with significantly worse PFS (9.1 vs. 14.7 months; p = 0.037) than peripheral disease, but LRC did not differ between the groups (p = 0.240). Grade ≥ 3 oral mucositis occurred in 7.7%, with no grade 4–5 acute events. Within a median follow-up of 9.3 months, late osteoradionecrosis affected 6.2%, but late toxicity data remain preliminary given the short follow-up. Ninety-two percent of patients completed treatment. Conclusions: PBS-IMPT re-irradiation provided adequate survival with low acute toxicity. T3–T4 stage at re-irradiation was the only variable retaining significance for PFS on multivariable analysis (HR 4.32, 95% CI 1.24–15.13; p = 0.022). The poor survival observed for central/skull-base disease on Kaplan–Meier curves disappeared after T-stage adjustment, indicating the higher concentration of advanced disease in that compartment. Multicentre prospective data and longer follow-up are needed.

  • Open Access

    Intercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results

    by Evangelina Martínez-Francés, Verónica Morán, Ana M. Romero, J. Pablo Cabello-García, Alberto Viñals, Javier Burguete, Sergio Rivera, Rafael Rodríguez, Roberto Méndez, Carles Domingo, et al.


  • Open Access

    Análisis de un protocolo de radioterapia guiada por imagen con marcadores fiduciales en radioterapia prostática hipofraccionada

    by Roser Fayos-Solá Capilla, Pablo Castro Tejero, Almudena Zapatero Laborda, David Hernández González, María Roch González, Alberto Viñals Muñoz, Paloma Botella Faus

    El objetivo principal de este trabajo es el evaluar la validez de un protocolo de radioterapia guiada por imagen (IGRT) implementado en casos de cáncer de próstata con implantación de marcadores fiduciales, así como caracterizar la magnitud de los desplazamientos intrafracción durante las cinco primeras sesiones de un grupo de 32 pacientes tratados a lo largo de un año. Dos semanas antes de la simulación se le implanta al paciente un mínimo de 3 marcadores fiduciales de oro intraprostáticos. Durante el tratamiento, con el uso combinado del sistema Auto Beam Hold (ABH) y la adquisición de imágenes pareadas kV-MV, se analiza el correcto posicionamiento de la zona a tratar y del paciente. De los resultados obtenidos, encontramos que ciertos pacientes acumulan la mayor parte de las interrupciones, lo que apunta a aquéllos que tendrían problemas en el posicionamiento desde el inicio y nos permite valorar la ampliación del seguimiento en determinados casos. Los resultados de los desplazamientos indican que todos los casos requieren correcciones menores de 5 mm. El uso de protocolos de radioterapia guiada por imagen (IGRT) en casos de anatomías variables, representa una mejora en el correcto posicionamiento del paciente y, por consiguiente, en la administración del tratamiento.